SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-290046
Filing Date
2019-11-12
Accepted
2019-11-12 16:46:02
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d822537d10q.htm 10-Q 685212
2 EX-31.1 d822537dex311.htm EX-31.1 6449
3 EX-31.2 d822537dex312.htm EX-31.2 6328
4 EX-32.1 d822537dex321.htm EX-32.1 6183
  Complete submission text file 0001193125-19-290046.txt   4145566

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20190930.xml EX-101.INS 930719
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20190930.xsd EX-101.SCH 37842
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20190930_cal.xml EX-101.CAL 36700
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20190930_def.xml EX-101.DEF 135098
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20190930_lab.xml EX-101.LAB 331440
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20190930_pre.xml EX-101.PRE 247106
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 191210314
SIC: 2834 Pharmaceutical Preparations